Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
about
Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunctionMicroglia in human immunodeficiency virus-associated neurodegeneration.Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsThe cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells.Cholesterol-dependent modulation of the toxicity of HIV-1 coat protein gp120 in human neuroblastoma cells.
P2860
Q30399828-3117274A-FB1F-4816-A7C4-91F337B3CAAFQ33308928-416BDB8E-CD28-4CC8-952C-72912779A525Q34963796-8CE224D5-E6F6-4C25-8772-261010E7AEE9Q35702700-8153751F-148C-4E2A-9476-57437D4F283FQ36526260-2821EAE5-B3EB-4125-91A4-5BEDDDD82062Q37522883-BBAF2D07-037C-4624-B8A5-7F6D2F855EF7Q40142273-D20407FD-341F-4EB9-AD4F-BA8EF1B294DCQ42039032-3E20BF6B-7BF4-4E4B-BA7A-7AB1A0A8034AQ43766395-660A7FF7-6CDF-4E35-BCB5-CEE4F134A003
P2860
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@ast
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@en
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@nl
type
label
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@ast
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@en
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@nl
prefLabel
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@ast
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@en
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.
@nl
P50
P1476
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo
@en
P2093
D Rotiroti
M Maccarrone
P356
10.1046/J.1471-4159.2001.00537.X
P407
P577
2001-10-01T00:00:00Z